Delivery Order SPE2DE24D0013-SPE2D625F3SLW
- Not listed
- The U.S. Defense Logistics Agency, through its Medical Supply Chain division, awarded a $3,638 firm fixed-price delivery order to Cepheid Inc. (UEI: W6HQTMWB9Q28) on May 30, 2025, with an ultimate completion date of June 13, 2025. This delivery order, designated XPCOV2/FLU/RSV-10, carries no set-aside designation and is for molecular diagnostic testing solutions related to COVID-19, influenza, and respiratory syncytial virus detection. The work will be performed at Cepheid's facility in...
- The U.S. Defense Logistics Agency's Medical Supply Chain division awarded a $17,000 firm fixed-price delivery order to Cepheid Inc. (UEI: W6HQTMWB9Q28) on August 19, 2025, for molecular diagnostic solutions related to COVID-19, influenza, and respiratory syncytial virus testing. The contract, designated as XPCOV2/FLU/RSV-10, has an ultimate completion date of August 26, 2025, and will be performed at Cepheid's headquarters in Sunnyvale, California. No small business set-aside was utilized for...
- The Defense Logistics Agency's Medical Supply Chain division awarded a $5,174.64 firm fixed-price delivery order to Cepheid Inc. (UEI: W6HQTMWB9Q28), a Sunnyvale, California-based manufacturer of molecular diagnostic solutions. This delivery order, designated XPCOV2/FLU/RSV-10, has an ultimate completion date of July 30, 2025, and carries no set-aside designation. The contract references diagnostic testing for COVID-19, influenza, and respiratory syncytial virus (RSV), consistent with...
- The U.S. Defense Medical Supply Chain awarded a firm fixed-price delivery order valued at $10,200 to Cepheid Inc. (UEI: W6HQTMWB9Q28) on August 15, 2025, with completion scheduled for August 22, 2025. The delivery order, designated 4569128836 for XPCOV2/FLU/RSV-10 diagnostic solutions, carries no set-aside designation and will be performed at Cepheid's Sunnyvale, California facility. This award represents procurement of molecular diagnostic testing capabilities, specifically for detection of...
- The U.S. Defense Department's Medical Supply Chain agency awarded a $12,040 firm fixed-price delivery order to Cepheid Inc. (UEI: W6HQTMWB9Q28) on August 21, 2025, with completion expected by August 28, 2025. This delivery order, designated XPCOV2/FLU/RSV-10, does not utilize a set-aside designation and will be performed at Cepheid's facility in Sunnyvale, California. The award supports the federal government's diagnostic testing capabilities through Cepheid's molecular diagnostic solutions,...
- The Defense Logistics Agency's Medical Supply Chain division awarded a $12,694.80 firm fixed-price delivery order to Cepheid Inc. (UEI: W6HQTMWB9Q28) on September 9, 2025, for molecular diagnostic testing solutions. The delivery order, designated XPCOV2/FLU/RSV-10, is scheduled for completion by September 16, 2025, and will be performed at Cepheid's Sunnyvale, California facility. This award carries no set-aside designation and represents a routine procurement under the company's existing...
- The U.S. Defense Logistics Agency, operating under the Medical Supply Chain division, awarded a $14,448 firm fixed-price delivery order to Cepheid Inc. on September 8, 2025, with an ultimate completion date of September 15, 2025. This delivery order, designated XPCOV2/FLU/RSV-10, procures molecular diagnostic testing solutions, specifically for COVID-19, influenza, and respiratory syncytial virus (RSV) detection. The contract carries no set-aside designation and will be performed at Cepheid's...
- The U.S. Defense Logistics Agency, operating under the Medical Supply Chain function, awarded a $20.4K firm fixed-price delivery order to Cepheid Inc. on September 18, 2025, with a completion date of September 25, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, procures molecular diagnostic solutions for COVID-19, influenza, and respiratory syncytial virus (RSV) testing, with performance to be executed at Cepheid's facility in Sunnyvale, California. This award carries no set-aside...
- The U.S. Defense Health Agency, through the Medical Supply Chain, awarded a $40.8K firm fixed-price delivery order to Cepheid Inc. (UEI: W6HQTMWB9Q28) on August 12, 2025, for molecular diagnostic solutions with an ultimate completion date of August 19, 2025. This delivery order, designated 4569068770 and titled XPCOV2/FLU/RSV-10, leverages Cepheid's expertise in infectious disease diagnostics and carries no set-aside designation. The work will be performed at Cepheid's facility in Sunnyvale,...
- The U.S. Defense Logistics Agency, operating under the Medical Supply Chain division, awarded a delivery order valued at $3,400 to Cepheid Inc. on September 2, 2025, with an ultimate completion date of September 9, 2025. The contract, designated 4569302264, is for XPCOV2/FLU/RSV-10 products and services and carries a firm fixed-price structure with no set-aside designation. The work will be performed at Cepheid's facility in Sunnyvale, California. Cepheid is a for-profit molecular diagnostics...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D625F3SLWDelivery Order
The U.S. Defense Logistics Agency's Medical Supply Chain division awarded a delivery order valued at $2,040 to Cepheid Inc. (UEI: W6HQTMWB9Q28) on September 17, 2025, with an ultimate completion date of September 24, 2025. This firm fixed-price delivery order, designated XPCOV2/FLU/RSV-10, carries no set-aside provisions and will be performed at Cepheid's facility in Sunnyvale, California. The contract designation references diagnostic testing for COVID-19, influenza, and respiratory syncytial virus, consistent with Cepheid's core business of molecular diagnostic solutions for infectious disease detection. Cepheid is a for-profit manufacturer specializing in advanced molecular diagnostic systems and test kits, with an established track record supplying diagnostic equipment, reagents, and testing services to multiple federal healthcare agencies including the Department of Veterans Affairs and the Indian Health Service. This delivery order likely draws from one of Cepheid's existing Indefinite Delivery Vehicle contracts, most notably the VA's Veterans Integrated Service Network 21 IDV valued at $2.5 million, which covers PCR testing services for conditions including COVID-19, influenza, RSV, and other laboratory microbiology diagnostics. The relatively modest order value suggests this is a routine procurement fulfilling ongoing federal diagnostic testing requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 9/17/25 |